Endogenous cardiotonic steroids: physiology, pharmacology, and novel therapeutic targets. - sprookjes - yvandenbroek - TriplyDB

Endogenous cardiotonic steroids: physiology, pharmacology, and novel therapeutic targets.

Endogenous cardiotonic steroids: physiology, pharmacology, and novel therapeutic targets.

http://www.wikidata.org/entity/Q34605877

about

Monosaccharide digitoxin derivative sensitize human non-small cell lung cancer cells to anoikis through Mcl-1 proteasomal degradation Inhibitory effect of bufalin and cinobufagin on steroidogenesis via the activation of ERK in human adrenocortical cells Carbonylation Modification Regulates Na/K-ATPase Signaling and Salt Sensitivity: A Review and a Hypothesis "Oxygen Sensing" by Na,K-ATPase: These Miraculous Thiols Specialized Functional Diversity and Interactions of the Na,K-ATPase The physiological and clinical importance of sodium potassium ATPase in cardiovascular diseases Cardiotonic Steroids as Modulators of Neuroinflammation Chronic Kidney Disease and Fibrosis: The Role of Uremic Retention Solutes Regulation of renal function and structure by the signaling Na/K-ATPase The Trade-Off between Dietary Salt and Cardiovascular Disease; A Role for Na/K-ATPase Signaling?Hypertensive effects of the iv administration of picomoles of ouabain Novel role of ouabain as a cystogenic factor in autosomal dominant polycystic kidney disease Calcium oscillations triggered by cardiotonic steroids Regulation of Cardiac Remodeling by Cardiac Na(+)/K(+)-ATPase Isoforms Na+-K+-ATPase, a new class of plasma membrane receptors Ouabain-digoxin antagonism in rat arteries and neurones 21-Benzylidene digoxin: a proapoptotic cardenolide of cancer cells that up-regulates Na,K-ATPase and epithelial tight junctions Influence of N-methyl-D-aspartate receptors on ouabain activation of nuclear factor-κB in the rat hippocampus Photochemical Approaches to Complex Chemotypes: Applications in Natural Product Synthesis The Pressure of Aging.Cardiac Glycosides Activate the Tumor Suppressor and Viral Restriction Factor Promyelocytic Leukemia Protein (PML)The Concise Guide to PHARMACOLOGY 2013/14: transporters.The Renin-Angiotensin System in the Development of Salt-Sensitive Hypertension in Animal Models and Humans.Device-guided slow-breathing effects on end-tidal CO(2) and heart-rate variability Synthetic Receptors Induce Anti Angiogenic and Stress Signaling on Human First Trimester Cytotrophoblast Cells.Reduction of Na/K-ATPase affects cardiac remodeling and increases c-kit cell abundance in partial nephrectomized mice.Reciprocal regulation of endocytosis and metabolism Effects of Na/K-ATPase and its ligands on bone marrow stromal cell differentiation Brain Na(+), K(+)-ATPase Activity In Aging and Disease.Selectivity of digitalis glycosides for isoforms of human Na,K-ATPase.A synthetic thiourea-based tripodal receptor that impairs the function of human first trimester cytotrophoblast cells Ouabain stimulates a Na+/K+-ATPase-mediated SFK-activated signalling pathway that regulates tight junction function in the mouse blastocyst.Does increased water intake prevent disease progression in autosomal dominant polycystic kidney disease?Endogenous cardiotonic steroids and salt-sensitive hypertension.Renal ischemia regulates marinobufagenin release in humans.A new clinical multivariable model that predicts postoperative acute kidney injury: impact of endogenous ouabain Ammonium activates ouabain-activated signalling pathway in astrocytes: therapeutic potential of ouabain antagonist.Reduction in maternal circulating ouabain impairs offspring growth and kidney development Modulation of Na(+)-K(+)-ATPase cell surface abundance through structural determinants on the α1-subunit.Ouabain improves functional recovery following traumatic brain injury

P2860

Q23923209-1215C018-FB34-4C42-A2B1-C636F778F3D4 Q24605993-CA006A71-4E4F-4165-8369-075D879102FC Q26738296-340B3DAA-1B6C-4DDE-9B05-293B3A40BE97 Q26741122-3D20FACC-7F86-4A32-BECC-9671C4A82B52 Q26744084-604BEA47-5345-4C2E-8703-591B16A2133A Q26764938-BA94B29A-AE80-48AB-B5A6-B21AC140224F Q26766722-5E070B13-952F-47FA-A639-17D9A33A980D Q26784008-CB767B6C-BDA9-416F-B57D-8086BB6A856A Q26853429-E9B0B2C8-025A-4F03-B5BA-D51B01F8DF9D Q26865026-45960128-4A85-47B6-8820-F22BAFA576EB Q27006531-D58CF96B-FD07-4FE8-9F65-630FCEF30AA6 Q27011660-CA0736BB-C848-475E-A41F-12B7751EAFD2 Q27024509-EE9E3D19-1697-4DB0-8CAA-58C9ACA5B553 Q28078224-0810482D-5918-426F-84C3-B26A9B6D588C Q28272317-0FAA691F-2814-4230-B0CA-03C1973EB75B Q28304163-E0B54E0C-E5AE-440C-86A1-CAF914AF3175 Q28395505-5481B2CA-F975-484F-BB1E-0FF14E070B72 Q28574624-1D23AC6C-A442-40D7-B53B-DDEBC306E73C Q28830059-82BBECA0-E862-45A4-9A3C-724C41C2B9DD Q30240720-C005D0C8-7BF2-40CD-93D9-2DF6FD3BEA58 Q30385919-B09238E0-6317-40BD-88A3-7A9B06D234B8 Q30486743-314AA9B5-8F12-425C-9D83-33804604AA3C Q33664406-CD020E7A-A009-476D-9F05-734F9C2CFDD1 Q33745600-A37CF248-3FF7-4E93-AC69-06C5E68584B0 Q33748770-F36FE9B6-E5DE-40C3-9627-73E795C49484 Q33764626-CCE26A00-1501-47EC-A5F6-0312D4E870DF Q33796356-79B9B6CC-5FCB-4893-93E4-072C02AA8A25 Q33875634-EF753E04-0EED-4FD3-8180-80FCA7F4DFAC Q33882592-6DC4AFB4-FBD9-40C6-9AE8-8B15B2963F68 Q33911448-4DBD3FF4-38E8-4415-9D15-01BB13291222 Q33963982-B77A85D9-1479-40C8-8AE9-C5CC6F54420B Q34013727-D1AFB9FA-6862-421D-B86D-963B84D67813 Q34094366-AAA26A41-DB9D-47EE-8EB4-DFC795A95567 Q34103941-053C7B25-AAB4-48A1-8186-8F084C15FAD5 Q34222274-4FC65324-D31B-4609-A9DF-B53146AD3765 Q34354207-CE206BDE-DB35-49F4-951B-285917ECDDD3 Q34391607-7F3D10B8-F79D-41DA-BE1F-5A13CB151971 Q34442335-91CA92BD-A99E-4B12-AFEA-3004DFF02CED Q34501722-6E7353E3-77A1-4CC4-B107-5B4C9CCC58FF Q34546792-E9D5FDCC-EEE9-4AFD-B586-D153558AFB01

P2860

Endogenous cardiotonic steroids: physiology, pharmacology, and novel therapeutic targets.

http://www.wikidata.org/entity/Q34605877

description

2009 nî lūn-bûn

@nan

2009 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի մարտին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Endogenous cardiotonic steroids: physiology, pharmacology, and novel therapeutic targets.

@ast

Endogenous cardiotonic steroids: physiology, pharmacology, and novel therapeutic targets.

@en

Endogenous cardiotonic steroids: physiology, pharmacology, and novel therapeutic targets.

@nl

type

label

Endogenous cardiotonic steroids: physiology, pharmacology, and novel therapeutic targets.

@ast

Endogenous cardiotonic steroids: physiology, pharmacology, and novel therapeutic targets.

@en

Endogenous cardiotonic steroids: physiology, pharmacology, and novel therapeutic targets.

@nl

prefLabel

Endogenous cardiotonic steroids: physiology, pharmacology, and novel therapeutic targets.

@ast

Endogenous cardiotonic steroids: physiology, pharmacology, and novel therapeutic targets.

@en

Endogenous cardiotonic steroids: physiology, pharmacology, and novel therapeutic targets.

@nl

P1433

Q34605877-51BA6AA6-D579-431E-913D-E0CA2AEBA0AA

P1476

Q34605877-3F4B61F0-9079-472E-86D6-DE286F21FC51

P2093

Q34605877-10F7A688-7DDC-4C2B-9563-7428801DB8C5

Q34605877-141E3313-2345-4F46-9F1F-333C9EE66D1D

Q34605877-F9EEEFC8-673E-47C5-A705-CF8B87FA5D2D

P2860

Q34605877-00D516EA-FEC7-406A-9908-DC141EF2C12E

Q34605877-012B4F42-4DF2-4C56-A9D9-C3C9D912A027

Q34605877-01C1DA2C-D66B-4994-9CEE-6F33454134F1

Q34605877-02777B1F-D6BC-43A8-AE60-CCE8DA1E8F23

Q34605877-03029F70-6FA8-4E7B-97B1-092BFD5ADC3D

Q34605877-04045DD9-0C1E-4143-A94D-C6F57B97F7DC

Q34605877-040D644D-D0D8-4C40-A9B5-EA1C146FE29E

Q34605877-04451633-7DA6-4BCE-8D9E-B9E4DC69D86E

Q34605877-06282966-F40C-45DF-8A7A-B2E7478483B0

Q34605877-072AF417-3323-458D-8364-31BBA092DC64

P304

Q34605877-AE172EEB-71D7-4DF1-822B-5F47D2E24FB2

P31

Q34605877-F92FD5EB-3C89-4A54-9FAE-B72971E8E59A

P356

Q34605877-60453873-F3E6-4D1E-86A4-93C260F808D1

P433

Q34605877-30FA08EB-EF5E-4ACD-9B1E-4721BBC0B7F7

P478

Q34605877-80D61A1D-544B-490A-A981-CF16B34CD92C

P577

Q34605877-A6803C22-4596-4BC4-83DB-9C7B90B3F71B

P5875

Q34605877-ED63D5EF-B7E1-406D-9E74-CB979B4ABC7A

P698

Q34605877-5EFB803C-3D3B-46DF-84E3-D9123EE91722

P921

Q34605877-0ED5C5F6-7DCE-40B3-9C18-DBEAD9165BDF

P932

Q34605877-83581880-2E9C-4D0C-BE0D-A05302FE0891

P356

P1433

Pharmacological Reviews

P1476

Endogenous cardiotonic steroids: physiology, pharmacology, and novel therapeutic targets.

@en

P2093

Alexei Y Bagrov

http://www.w3.org/2001/XMLSchema#string

Joseph I Shapiro

http://www.w3.org/2001/XMLSchema#string

Olga V Fedorova

http://www.w3.org/2001/XMLSchema#string

P2860

A putative fourth Na+,K(+)-ATPase alpha-subunit gene is expressed in testis

Binding of Src to Na+/K+-ATPase forms a functional signaling complex

Identification and characterization of a ouabain-like compound from human plasma

Correlation of gene and protein structures in the FXYD family proteins

The FXYD gene family of small ion transport regulators or channels: cDNA sequence, protein signature sequence, and expression

Cicletanine reverses vasoconstriction induced by the endogenous sodium pump ligand, marinobufagenin, via a protein kinase C dependent mechanism

Myocardial PKC beta2 and the sensitivity of Na/K-ATPase to marinobufagenin are reduced by cicletanine in Dahl hypertension

The influence of some cations on an adenosine triphosphatase from peripheral nerves

The family of human Na+,K+-ATPase genes. No less than five genes and/or pseudogenes related to the alpha-subunit

Hypertension-linked mutation in the adducin alpha-subunit leads to higher AP2-mu2 phosphorylation and impaired Na+,K+-ATPase trafficking in response to GPCR signals and intracellular sodium

P304

9-38

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1124/PR.108.000711

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

61

http://www.w3.org/2001/XMLSchema#string

P577

2009-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

24237806

http://www.w3.org/2001/XMLSchema#string

P698

19325075

http://www.w3.org/2001/XMLSchema#string

P921

P932

2763610

http://www.w3.org/2001/XMLSchema#string